MRNX Price Forecast & ETF Analysis. Dividend · Expense Ratio · Holdings · NAV · RSI · MACD | US Stocks Today
Full metrics table
| Category | Equity - Leveraged / Inverse | Expense | 1.34% | Return% 1Y | - | Total Holdings | 9 | Perf Week | -27.52% | Volume | 198,422 |
| Asset Type | Equities (Stocks) | AUM | $36M | Return% 3Y | - | NAV | $134.36 | Perf Month | -12.3% | Avg Volume | 0.34M |
| ETF Type | US Equities | Dividend TTM | - | Return% 5Y | - | 52W High | -42.03% | Perf Quarter | 421.04% | Rel Volume | 0.58 |
| Active/Passive | Active | Div Gr. 3/5Y | - | Return% 10Y | - | 52W Low | 783.68% | Perf Half Y | 464.1% | Prev Close | $133.61 |
| IPO | 2026/2/4 | Flows% 1M | 47.88% | Return% SI | 1287.32% | RSI (14) | 46.14 | Perf YTD | 541% | Price | $132.11 |
| Beta | - | Flows% 3M | 129.77% | Flows% YTD | 144.08% | Flows% 1Y | 144.08% | Perf Year | - | Volatility(W/M) | 38.99% 22.71% |
| SMA20 | -17.85% | SMA50 | 9.88% | SMA200 | 148.89% | ATR | 31.48 | ||||
Defiance Daily Target 2X Long MRNA ETF is an actively managed, single-stock leveraged exchange-traded fund designed to provide 200% of the daily share price performance of Moderna, Inc. (MRNA). The fund is intended for sophisticated investors and active traders who seek to express tactical bullish views on mRNA-based biotechnology innovation through amplified daily exposure.
It moves 2x the daily move of the index
Its value erodes over time. It is built for trades of a day or two, not for holding.
The top 3 make up 29% of the fund
Spread evenly across many holdings.
Over the past 1 year, roughly in the middle
42% below its 1-year high.
Traded less than usual. That is 58% of its average volume.
Long-term returns are roughly flat
Tap to view numbers
The price swings wildly
At its worst (July 2026) it fell 60% and took 13 days to recover.
Tap to view numbers
No dividend
There is no profit to distribute yet.
Money keeps flowing in
Over the past year, new money equal to 144.1% of assets came in.
Tap to view numbers